Mihaela Munteanu
Impact in
-
- Lymphoma Diagnosis and Treatment
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Lymphoma Diagnosis and Treatment 13
- Oncology 13
- Cancer Immunotherapy and Biomarkers 4
- Co-authors
- Ian W. Flinn (8 shared papers)John M. Burke (8 shared papers)Samar Issa (6 shared papers)David Simpson (6 shared papers)Tim E. Hawkins (6 shared papers)Kathryn S. Kolibaba (6 shared papers)Mark Hertzberg (6 shared papers)Brad S. Kahl (7 shared papers)
- Journals
- Blood (6 papers)BMC Cancer (6 papers)Journal of Clinical Oncology (6 papers)Investigational New Drugs (4 papers)Annals of Hematology (2 papers)
- Partner nations
- United StatesRomaniaAustralia
In The Last Decade
Mihaela Munteanu
55 papers receiving 1.1k citations
Mihaela Munteanu's Hit Papers
Peers
Comparison fields: 5 of 76
- Pathology and Forensic Medicine 537
- Genetics 300
- Oncology 461
- Hematology 169
- Biological Psychiatry 34
Countries citing papers authored by Mihaela Munteanu
This map shows the geographic impact of Mihaela Munteanu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mihaela Munteanu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mihaela Munteanu more than expected).
Fields of papers citing papers by Mihaela Munteanu
This network shows the impact of papers produced by Mihaela Munteanu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mihaela Munteanu. The network helps show where Mihaela Munteanu may publish in the future.
Co-authors
The 25 scholars most cited alongside Mihaela Munteanu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study Hit paper breakdown → | 2014 | 440 |
| 2 | 2002 | 179 | |
| 3 | 2005 | 93 | |
| 4 | 2015 | 38 | |
| 5 | 2018 | 36 | |
| 6 | 2013 | 27 | |
| 7 | 2012 | 26 | |
| 8 | 2015 | 23 | |
| 9 | Prognosis of colorectal cancer: clinical, pathological and therapeutic correlation. | 2012 | 22 |
| 10 | 2015 | 22 | |
| 11 | 2014 | 20 | |
| 12 | 2015 | 16 | |
| 13 | 2024 | 15 | |
| 14 | Preliminary report of the safety and efficacy of gemtuzumab ozogamicin (Mylotarg (R)) given in combination with cytarabine and daunorubicin in patients with acute myeloid leukemia | 2001 | 15 |
| 15 | 2016 | 14 | |
| 16 | 2016 | 13 | |
| 17 | 2024 | 13 | |
| 18 | 2013 | 10 | |
| 19 | 2020 | 10 | |
| 20 | 2024 | 8 |
About Mihaela Munteanu
Mihaela Munteanu is a scholar working on Pathology and Forensic Medicine, Oncology, Genetics, Hematology and Public Health, Environmental and Occupational Health, having authored 62 papers that have together received 1.2k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (13 papers), Chronic Lymphocytic Leukemia Research (10 papers), Acute Myeloid Leukemia Research (6 papers), Chronic Myeloid Leukemia Treatments (5 papers), Acute Lymphoblastic Leukemia research (5 papers), Tryptophan and brain disorders (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Receptor Mechanisms and Signaling (3 papers). The work is most often cited by research in Pathology and Forensic Medicine (537 citations), Genetics (300 citations), Oncology (461 citations), Hematology (169 citations) and Biological Psychiatry (34 citations). Mihaela Munteanu has collaborated with scholars based in United States, Romania and Australia. Frequent co-authors include Ian W. Flinn, John M. Burke, Samar Issa, David Simpson, Tim E. Hawkins, Kathryn S. Kolibaba, Mark Hertzberg, Brad S. Kahl, David MacDonald and Peter Wood. Their work appears in journals such as Blood, BMC Cancer, Journal of Clinical Oncology, Investigational New Drugs and Annals of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.